FDA actions authorize serology tests, N95 sterilization process
The Food and Drug Administration this week issued a pair of emergency use authorizations for serology tests to detect for the presence of coronavirus antibodies. The EUAs were issued to for its VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and for its DPP COVID-19 IgM/IgG System.
FDA also the emergency use of Stryker Instrument’s Sterizone VP4 Sterilizer1 N95 Respirator Decontamination Cycle for single reuse by health care personnel to prevent exposure to pathogenic biological airborne particulates when there are insufficient supplies of face-filtering respirators.
Related News Articles
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…